Molecular Heterogeneity of Inflammatory Breast Cancer: A Hyperproliferative Phenotype
Open Access
- 1 September 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 12 (17) , 5047-5054
- https://doi.org/10.1158/1078-0432.ccr-05-2248
Abstract
Purpose: Inflammatory breast cancer (IBC) is associated with very poor prognosis. The aims of this study are (a) to prospectively identify differential gene expression patterns associated with IBC and (b) to confirm these pathways using tissue arrays.Keywords
This publication has 26 references indexed in Scilit:
- Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray AnalysisBreast Cancer Research and Treatment, 2005
- Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast CancerCancer Research, 2005
- Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to ChemotherapyCancer Research, 2004
- Molecular Profiling of Inflammatory Breast CancerClinical Cancer Research, 2004
- Immunophenotypic analysis of inflammatory breast cancers: identification of an ‘inflammatory signature’The Journal of Pathology, 2004
- Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer DatabasesJournal of Clinical Oncology, 2003
- Is p53 a breast cancer gene?Cancer Biology & Therapy, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Cell kinetics and hormonal receptor status in inflammatory breast carcinoma. Comparison with locally advanced diseaseCancer, 1989
- Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsBreast Cancer Research and Treatment, 1982